Carmine Therapeutics Competitors and Similar CompaniesClear all
Carmine Therapeutics's competitors and similar companies include Ionis Pharmaceuticals, Intellia Therapeutics, CRISPR Therapeutics and Omega Therapeutics.
 Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. |  Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry. |  CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. | |||
Founding Date | Founding Date 2019 | Founding Date 1989 | Founding Date 2014 | Founding Date 2013 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ Singapore, SG | Locations Cambridge, US HQ | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US | Locations Cambridge, US HQ | |
Employees | Employees 7 | Employees 1,40231% increase | Employees 40323% decrease | Employees 393 | Employees 60 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 6.3 b | Valuation ($) 1.7 b | Valuation ($) 4.2 b | Valuation ($) 68.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $943.7m (FY, 2025) | Revenue (est.) $67.7m (FY, 2025) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $3.1m (FY, 2023) |
Net income | Net income N/A | Net income ($381.4m) (FY, 2025) | Net income ($412.7m) (FY, 2025) | Net income ($581.6m) (FY, 2025) | Net income ($97.4m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 3.4m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 127m | Total funding raised $ 211m |
For sources of this data, please see the company profile
View Company Profiles
Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
1,402↑ 31% increase
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View companyIntellia Therapeutics
HQ
Cambridge, US
Employees
403↓ 23% decrease
Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.
View companyCRISPR Therapeutics
HQ
Zug, CH
Employees
393
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View company
Omega Therapeutics
HQ
Cambridge, US
Employees
60
Omega Therapeutics is an epigenomic medicine company.
View company